EZZ Life Science Holdings Limited

ASX:EZZ.AX

3.5 (AUD) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019
Revenue 66.44337.14315.02222.28717.31511.187
Cost of Revenue 17.1529.947.5149.82813.7536.827
Gross Profit 49.29127.2037.50912.4593.5624.361
Gross Profit Ratio 0.7420.7320.50.5590.2060.39
Reseach & Development Expenses 000000
General & Administrative Expenses 01.1450.8960.6820.2960.9
Selling & Marketing Expenses 020.5582.9697.8431.5541.969
SG&A 39.57422.5883.8658.5262.0823.183
Other Expenses 00.2590.1410.17500
Operating Expenses 39.57422.5885.8669.8862.0823.183
Operating Income 9.7174.6151.7842.7481.481.177
Operating Income Ratio 0.1460.1240.1190.1230.0850.105
Total Other Income Expenses Net 0.2430.2850.1410.1750.67-0
Income Before Tax 9.9594.9011.782.7372.151.177
Income Before Tax Ratio 0.150.1320.1180.1230.1240.105
Income Tax Expense 2.9951.2710.4670.7060.5640.354
Net Income 6.9643.631.3122.0311.5860.824
Net Income Ratio 0.1050.0980.0870.0910.0920.074
EPS 0.160.0850.0310.0480.0380.02
EPS Diluted 0.160.0850.0310.0480.0380.02
EBITDA 10.1084.7971.9032.8731.6261.181
EBITDA Ratio 0.1520.1290.1270.1290.0940.106